Normal view MARC view ISBD view

Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test. [electronic resource]

By:

Javaherian, Mahdieh

Contributor(s):

Producer: 20150508Description: 8-13 p. digitalISSN:

2008-3289

In: Iranian journal of microbiology vol. 6

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

4781 A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
by Park, Inkeun
4782 A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
by Kurimoto, Keisuke
4783 [Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
by Takayama, Tatsuya
4784 A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.
by Hata, Taishi
4785 CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
by Lee, Dae-Won
4786 Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II study.
by Niho, Seiji
4787 Usefulness of chemoradiotherapy for inoperable gastric cancer.
by Taki, T
4788 Meta-analysis for the efficacy of S-1-based regimens as the first-line treatment in Asian chemotherapy-naive patients with advanced non-small-cell lung cancer.
by Chen, Jianxin
4789 Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia.
by Kawamura, Taiichi
4790 Short-term curative effect of S-1 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer: a prospective comparison study.
by Zhao, Qun
4791 Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
by Chihara, Yusuke
4792 Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy.
by Nakamura, Yoshiaki
4793 Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
by Miyanaga, Akihiko
4794 Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002).
by Takahari, Daisuke
4795 [Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
by Aoki, Y
4796 Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice.
by Louvet, C
4797 Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
by Kusunoki, M
4798 [Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
by Basaki, Yuji
4799 Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer.
by Chakrapee-Sirisuk, S
4800 5-FU improves p27-related poor prognosis in patients with Astler-Coller B2-C colorectal carcinoma.
by Kobayashi, Minako